Involvement of ERK and CREB signaling pathways in the protective effect of PACAP in monosodium glutamate-induced retinal lesion

Ann N Y Acad Sci. 2006 Jul:1070:507-11. doi: 10.1196/annals.1317.070.

Abstract

Pituitary adenylate cyclase-activating polypeptide (PACAP) has well-documented neuroprotective actions, which have also been shown in retinal degeneration induced by monosodium glutamate (MSG) in neonatal rats. The aim of this article was to investigate the activation of extracellular signal-regulated kinase (ERK1/2) and cyclic adenosine 3',5'-phosphate (cAMP)-responsive element binding protein (CREB) signaling pathways by Western blot analysis in retinal degeneration induced by MSG. We found that intravitreal administration of PACAP preceding the MSG treatments induced significant increases in the phosphorylation, that is, the activation of ERK1/2 and its downstream target, CREB, 12 h after the treatment compared to the contralateral untreated eye during the first two treatments, with no further elevations 24 h after treatments. These results demonstrate that the degenerative effect of MSG and the protective effect of PACAP involve complex kinase signaling pathways and are related to cAMP/ERK/CREB activation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cyclic AMP Response Element-Binding Protein / metabolism*
  • Extracellular Signal-Regulated MAP Kinases / metabolism*
  • Phosphorylation / drug effects
  • Pituitary Adenylate Cyclase-Activating Polypeptide / pharmacology*
  • Rats
  • Rats, Wistar
  • Retina / drug effects*
  • Retina / metabolism*
  • Signal Transduction / drug effects*
  • Sodium Glutamate / pharmacology*

Substances

  • Cyclic AMP Response Element-Binding Protein
  • Pituitary Adenylate Cyclase-Activating Polypeptide
  • Extracellular Signal-Regulated MAP Kinases
  • Sodium Glutamate